IEX •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization277.85 mln
Float38.87 mln
Earnings Date08/06/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-1.51
Likely manipulated
1-Year Forecast
12.62
Transformational upside
Relative Strength
21
/ 100
Significantly lagging
Debt / Equity
0.03
Debt-free
ROE
-34.31
Deeply negative
Business Description
Founded in 2009 and based in Cambridge, UK, Bicycle Therapeutics is a clinical-stage drug company working on a new type of medicine designed to treat conditions that current therapies have failed to adequately address. The company's core technology produces small, precisely engineered molecules that can target cancer cells and other diseases with a high degree of accuracy, with several treatments currently in clinical trials targeting various tumor types and early-stage research underway in nervous system and neuromuscular diseases. Bicycle Therapeutics works alongside several major pharmaceutical companies, including Novartis, AstraZeneca, and Genentech, to expand the reach of its research across multiple disease areas.
